Meeting
Abstract Number: 470
SHM Converge 2024
Case Presentation: Asenapine is widely acknowledged as a well-tolerated medication, exhibiting only infrequent severe adverse events1. The necessity of liver enzyme testing remains a topic without a unanimous consensus2. This case study discusses a patient who experienced significant liver damage upon initiating asenapine. As far as our understanding goes, this represents the initial documented instance […]